HK1069762A1 - Use of il-18 inhibitors for treating or preventingcns injuries - Google Patents
Use of il-18 inhibitors for treating or preventingcns injuriesInfo
- Publication number
- HK1069762A1 HK1069762A1 HK04110391A HK04110391A HK1069762A1 HK 1069762 A1 HK1069762 A1 HK 1069762A1 HK 04110391 A HK04110391 A HK 04110391A HK 04110391 A HK04110391 A HK 04110391A HK 1069762 A1 HK1069762 A1 HK 1069762A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preventingcns
- injuries
- inhibitors
- treating
- preventingcns injuries
- Prior art date
Links
- 230000006378 damage Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01112067 | 2001-05-25 | ||
| PCT/EP2002/005666 WO2002096456A1 (en) | 2001-05-25 | 2002-05-23 | Use of il-18 inhibitors for treating or preventing cns injuries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1069762A1 true HK1069762A1 (en) | 2005-06-03 |
Family
ID=8177454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04110391A HK1069762A1 (en) | 2001-05-25 | 2004-12-31 | Use of il-18 inhibitors for treating or preventingcns injuries |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7655616B2 (xx) |
| EP (1) | EP1390070B1 (xx) |
| JP (1) | JP4344142B2 (xx) |
| KR (1) | KR20040030625A (xx) |
| CN (1) | CN1305529C (xx) |
| AU (1) | AU2002314103B2 (xx) |
| BG (1) | BG66395B1 (xx) |
| BR (1) | BR0210007A (xx) |
| CA (1) | CA2445664C (xx) |
| CY (1) | CY1119190T1 (xx) |
| CZ (1) | CZ307321B6 (xx) |
| DK (1) | DK1390070T3 (xx) |
| EA (1) | EA006744B1 (xx) |
| EE (1) | EE05263B1 (xx) |
| ES (1) | ES2617084T3 (xx) |
| HK (1) | HK1069762A1 (xx) |
| HR (1) | HRP20030842B1 (xx) |
| HU (1) | HU230294B1 (xx) |
| IL (2) | IL159014A0 (xx) |
| LT (1) | LT1390070T (xx) |
| ME (1) | ME00550B (xx) |
| MX (1) | MXPA03010743A (xx) |
| NO (1) | NO331882B1 (xx) |
| PL (1) | PL216228B1 (xx) |
| PT (1) | PT1390070T (xx) |
| RS (1) | RS56006B1 (xx) |
| SK (1) | SK288413B6 (xx) |
| UA (1) | UA80396C2 (xx) |
| WO (1) | WO2002096456A1 (xx) |
| ZA (1) | ZA200308172B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1622939T1 (sl) | 2003-05-13 | 2012-06-29 | Merck Serono Sa | Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega |
| JP5069000B2 (ja) * | 2004-06-30 | 2012-11-07 | 敦生 関山 | 非炎症性ストレス応答の指標剤およびその利用 |
| PL1888100T3 (pl) * | 2005-06-03 | 2012-03-30 | Merck Serono Sa | Zastosowanie lizoform IL-18BP do leczenia i/lub zapobiegania neurologicznym chorobom zapalnym |
| DK1885753T3 (da) | 2005-06-03 | 2011-10-03 | Ares Trading Sa | Fremstilling af rekombinant II-18-proteiner |
| DK1891088T3 (da) | 2005-06-10 | 2012-01-30 | Ares Trading Sa | Fremgangsmåde til rensning af et IL-18-bindende protein |
| US8685400B2 (en) * | 2007-07-30 | 2014-04-01 | University Of Miami | Modulating inflammasome activity and inflammation in the central nervous system |
| WO2015032932A1 (en) * | 2013-09-05 | 2015-03-12 | Ab2 Bio Sa | Il-18 binding protein (il-18bp) in inflammatory diseases |
| MX2017010919A (es) * | 2015-03-05 | 2017-12-07 | Ab2 Bio Sa | Proteina de union il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0873453A (ja) * | 1994-09-02 | 1996-03-19 | Otsuka Pharmaceut Co Ltd | サイトカイン阻害剤 |
| IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
| DE69925581T2 (de) * | 1998-03-09 | 2006-04-27 | Vertex Pharmaceuticals Inc., Cambridge | 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms |
| CA2276216A1 (en) * | 1998-06-24 | 1999-12-24 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | An artificial peptide capable of neutralizing the biological activity of interleukin-18 |
| RS50926B (sr) * | 2000-05-05 | 2010-08-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Upotreba il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze |
| DE60106026T2 (de) * | 2000-06-23 | 2006-02-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag)-ein hemmer des tumor nekrose faktors-alfa und neuroprotektor des gehirns bei geschlossenen kopfverletzungen |
| AU2002224417A1 (en) * | 2000-10-18 | 2002-04-29 | Immunex Corporation | Methods for treating il-18 mediated disorders |
| US6671553B1 (en) * | 2001-05-23 | 2003-12-30 | Pacesetter, Inc. | Implantable cardiac lead having terminating connector strain relief and method of manufacture |
-
2002
- 2002-05-23 JP JP2002592965A patent/JP4344142B2/ja not_active Expired - Lifetime
- 2002-05-23 MX MXPA03010743A patent/MXPA03010743A/es active IP Right Grant
- 2002-05-23 BR BR0210007-0A patent/BR0210007A/pt not_active Application Discontinuation
- 2002-05-23 CN CNB028147510A patent/CN1305529C/zh not_active Expired - Lifetime
- 2002-05-23 CA CA2445664A patent/CA2445664C/en not_active Expired - Lifetime
- 2002-05-23 EA EA200301299A patent/EA006744B1/ru not_active IP Right Cessation
- 2002-05-23 RS YU89403A patent/RS56006B1/sr unknown
- 2002-05-23 KR KR10-2003-7015310A patent/KR20040030625A/ko active Search and Examination
- 2002-05-23 EP EP02740641.2A patent/EP1390070B1/en not_active Expired - Lifetime
- 2002-05-23 HU HU0304067A patent/HU230294B1/hu unknown
- 2002-05-23 ME MEP-2008-618A patent/ME00550B/me unknown
- 2002-05-23 LT LTEP02740641.2T patent/LT1390070T/lt unknown
- 2002-05-23 UA UA20031212328A patent/UA80396C2/uk unknown
- 2002-05-23 WO PCT/EP2002/005666 patent/WO2002096456A1/en active IP Right Grant
- 2002-05-23 SK SK1603-2003A patent/SK288413B6/sk not_active IP Right Cessation
- 2002-05-23 CZ CZ2003-3268A patent/CZ307321B6/cs not_active IP Right Cessation
- 2002-05-23 ES ES02740641.2T patent/ES2617084T3/es not_active Expired - Lifetime
- 2002-05-23 IL IL15901402A patent/IL159014A0/xx unknown
- 2002-05-23 DK DK02740641.2T patent/DK1390070T3/en active
- 2002-05-23 PT PT2740641T patent/PT1390070T/pt unknown
- 2002-05-23 US US10/478,614 patent/US7655616B2/en not_active Expired - Lifetime
- 2002-05-23 EE EEP200300582A patent/EE05263B1/xx unknown
- 2002-05-23 AU AU2002314103A patent/AU2002314103B2/en not_active Expired
- 2002-05-23 PL PL367545A patent/PL216228B1/pl unknown
-
2003
- 2003-10-17 HR HRP20030842AA patent/HRP20030842B1/hr not_active IP Right Cessation
- 2003-10-21 ZA ZA200308172A patent/ZA200308172B/xx unknown
- 2003-11-20 NO NO20035160A patent/NO331882B1/no not_active IP Right Cessation
- 2003-11-23 IL IL159014A patent/IL159014A/en active IP Right Grant
- 2003-12-15 BG BG108451A patent/BG66395B1/bg unknown
-
2004
- 2004-12-31 HK HK04110391A patent/HK1069762A1/xx not_active IP Right Cessation
-
2017
- 2017-05-08 CY CY20171100494T patent/CY1119190T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002339157A1 (en) | Inhibitors of the notch signalling pathway for use in the treatment of cancer | |
| HK1094909A1 (en) | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis il-18 | |
| AU2002334969A1 (en) | Use of stat-6 inhibitors as therapeutic agents | |
| HK1068551A1 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
| HUP0300061A3 (en) | Use of il-18 inhibitors | |
| AU7753401A (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity | |
| EP1359885A4 (en) | NOS-HEMMER FOR THE TREATMENT OF WRINKLES | |
| HK1062810A1 (en) | Use of il-18 inhibitors for the manufacture of medicaments for treatment and/or prevention of heartdisease | |
| HK1069762A1 (en) | Use of il-18 inhibitors for treating or preventingcns injuries | |
| GB0124124D0 (en) | Methods of treatment | |
| IL162509A0 (en) | Use of deoxypeganine for treating clinical depression | |
| IL160230A0 (en) | Use of il-18 inhibitors | |
| IL161630A0 (en) | Methods of treating endometreosis | |
| HK1062806A1 (en) | Novel methods for the treatment and prevention of pain using stress- activated protein kinase inhibitors | |
| GB0129388D0 (en) | Use of compounds for treating cancer | |
| GB0119115D0 (en) | Formulation for treatment of gallstones | |
| SI1487829T1 (sl) | Tiadiazolilpiperazinski derivati, uporabni za zdravljenje ali preprecevanje bolecine | |
| SI1307262T1 (en) | Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity | |
| GB0118627D0 (en) | Use of compounds in therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PE | Patent expired |
Effective date: 20220522 |